Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.46
+1.79 (7.56%)
Feb 18, 2026, 4:00 PM EST - Market closed
Pulse Biosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Pulse Biosciences stock has a target of 22, which predicts a -13.59% decrease from the current stock price of 25.46.
Price Target: $22 (-13.59%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 7, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Pulse Biosciences is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | -13.59% | Jul 7, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 13, 2022 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | -52.87% | Apr 1, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $8.5 | Strong Buy | Maintains | $20 → $8.5 | -66.61% | Apr 1, 2022 |
Financial Forecast
Revenue This Year
255.00K
Revenue Next Year
3.44M
from 255.00K
Increased by 1,250.20%
EPS This Year
-1.22
from -0.92
EPS Next Year
-1.52
from -1.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 315,000 | 3.9M | ||||
| Avg | 255,000 | 3.4M | ||||
| Low | 196,000 | 2.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 1,444.3% | ||||
| Avg | - | 1,250.2% | ||||
| Low | - | 1,052.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.20 | -1.40 | ||||
| Avg | -1.22 | -1.52 | ||||
| Low | -1.23 | -1.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.